From genetic abnormality to metastases : murine models of breast cancer and their use in the development of anticancer therapies
Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with 99mTc
Use of raloxifene among women with a history of breast cancer
Bidirectional cross talk between ERα and EGFR signalling pathways regulates tamoxifen-resistant growth
Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade
EcoRI polymorphism of the metastasis-suppressor gene NME1 in Mexican patients with breast cancer
Neuregulins 1–4 are expressed in the cytoplasm or nuclei of ductal carcinoma (in situ) of the human breast
Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells
High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model
A possible regulatory role of 17β-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells
Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women